Provided by Tiger Trade Technology Pte. Ltd.

Fortress Biotech

2.09
+0.05002.45%
Post-market: 2.100.0100+0.48%19:46 EDT
Volume:265.71K
Turnover:550.27K
Market Cap:69.43M
PE:0.75
High:2.10
Open:2.03
Low:2.02
Close:2.04
52wk High:4.53
52wk Low:2.00
Shares:33.22M
Float Shares:21.42M
Volume Ratio:0.86
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):-0.0674
ROE:115.99%
ROA:-7.76%
PB:0.42
PE(LYR):-30.99

Loading ...

Fortress Biotech Repays Remaining $15 Million Senior Secured Debt, Exits Facility

Reuters
·
Oct 02

Journey Medical CEO Maraoui to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 09

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 08

Longeveron Names Nirav Jhaveri CFO, Replacing Interim Finance Chief Marie Washburn

Reuters
·
Aug 20

Fortress Biotech Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Fortress Biotech Q2 EPS $(0.08) Beats $(0.20) Estimate, Sales $18.718M Beat $18.300M Estimate

Benzinga Earnings
·
Aug 14

Fortress Biotech Q2 FY26 Turns to Net Loss of $2.5 Million; Revenue Rises 14% to $18.7 Million

Reuters
·
Aug 14

Press Release: Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Dow Jones
·
Aug 14

Journey Medical Climbs After Quarterly Revenue Beat

Reuters
·
Aug 13

Journey Medical Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Journey Medical Q2 Revenue Rises 23% to $18.5 Million on Emrosi Sales Growth

Reuters
·
Aug 13

Press Release: Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Dow Jones
·
Aug 13

Journey Medical Corp Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Reuters
·
Aug 11

Fortress Biotech Inc Expected to Post a Loss of 20 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Avenue Therapeutics Q2 Net Loss Narrows to $690,000; Revenue Drops to no Revenue

Reuters
·
Aug 07

Mustang Bio Q2 Net Loss Widens 41% to $1.07 Million

Reuters
·
Aug 06

Journey Medical to Report Q2 2026 Results, Host Conference Call

Reuters
·
Aug 05

Press Release: Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics' $130 Million Series B Financing

Dow Jones
·
Jul 27

Journey Medical Holds Annual Shareholder Meeting Online

Reuters
·
Jun 26

Fortress Biotech holds annual shareholder meeting

Reuters
·
Jun 24